<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35188017</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1521-0464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug delivery</Title>
          <ISOAbbreviation>Drug Deliv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chondroitin sulfate-functionalized lipid nanoreservoirs: a novel cartilage-targeting approach for intra-articular delivery of cassic acid for osteoarthritis treatment.</ArticleTitle>
        <Pagination>
          <StartPage>652</StartPage>
          <EndPage>663</EndPage>
          <MedlinePgn>652-663</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10717544.2022.2041130</ELocationID>
        <Abstract>
          <AbstractText>Novel intra-articular nanoreservoirs were implemented employing different cartilage targeting approaches to improve cartilage bioavailability of a chondroprotective drug, cassic acid (CA), for effective amelioration of cartilage deterioration off-targeting CA gastrointestinal disorders. Herein, we compared active cartilage-targeting approach via chondroitin sulfate (CHS) functionalization versus passive targeting using positively charged nanoparticles to target negatively charged cartilage matrix. Firstly, CA integrated nanoreservoirs (CA-NRs) were fabricated based on ionic conjugation between CA and cationic hydrophobic surface modifier octadecylamine (ODA) and were further functionalized with CHS to develop CHS-CA-NRs. Confocal laser microscope was used to visualize the accumulation of nanoparticles into the cartilage tissue. Both targeting approaches promoted CA local cartilage availability and prolonged its residence time. Compared to passive targeted CA-NRs, active targeted CHS-CA-NRs showed higher fluorescence signals in proximity to and inside chondrocytes which lasted for up to 21 days. In MIA-osteoarthritic rats, CHS-CA-NRs showed superior antiosteoarthritic activity, exhibiting highest cartilage repair compared to CA-NRs. Additionally, CHS-CA-NRs significantly inhibited OA inflammatory cytokine, degradation enzyme and oxidative stress and improved cartilage matrix biosynthesis. Conclusively, CHS-CA-NRs improved OA repair showing a superior efficacy for articular cartilage targeting with CHS which could be a potential advance for OA therapy.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ebada</LastName>
            <ForeName>Heba M K</ForeName>
            <Initials>HMK</Initials>
            <AffiliationInfo>
              <Affiliation>Central Lab, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nasra</LastName>
            <ForeName>Maha M A</ForeName>
            <Initials>MMA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nassra</LastName>
            <ForeName>Rasha A</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Biochemistery, Faculty of Medicine, Alexandria University, Alexandria, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdallah</LastName>
            <ForeName>Ossama Y</ForeName>
            <Initials>OY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drug Deliv</MedlineTA>
        <NlmUniqueID>9417471</NlmUniqueID>
        <ISSNLinking>1071-7544</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000880">Anthraquinones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004337">Drug Carriers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9007-28-7</RegistryNumber>
          <NameOfSubstance UI="D002809">Chondroitin Sulfates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YM64C2P6UX</RegistryNumber>
          <NameOfSubstance UI="C020491">rhein</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000880" MajorTopicYN="N">Anthraquinones</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002358" MajorTopicYN="N">Cartilage, Articular</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002626" MajorTopicYN="N">Chemistry, Pharmaceutical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002809" MajorTopicYN="N">Chondroitin Sulfates</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004337" MajorTopicYN="N">Drug Carriers</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065546" MajorTopicYN="N">Drug Liberation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053758" MajorTopicYN="N">Nanoparticles</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010003" MajorTopicYN="N">Osteoarthritis</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010316" MajorTopicYN="N">Particle Size</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013499" MajorTopicYN="N">Surface Properties</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Intra-articular delivery</Keyword>
        <Keyword MajorTopicYN="N">cartilage targeting</Keyword>
        <Keyword MajorTopicYN="N">cassic acid</Keyword>
        <Keyword MajorTopicYN="N">chondroitin sulfate</Keyword>
        <Keyword MajorTopicYN="N">osteoarthritis</Keyword>
      </KeywordList>
      <CoiStatement>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>21</Day>
          <Hour>8</Hour>
          <Minute>43</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35188017</ArticleId>
        <ArticleId IdType="pmc">PMC8865121</ArticleId>
        <ArticleId IdType="doi">10.1080/10717544.2022.2041130</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Allam AN, Hamdallah SI, Abdallah OY. (2017). Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation. Int J Nanomedicine
12:4733–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5503500</ArticleId>
            <ArticleId IdType="pubmed">28740381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almezgagi M, Zhang Y, Hezam K, et al.  (2020). Diacerein: recent insight into pharmacological activities and molecular pathways. Biomed Pharmacother
131:110594.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32858499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asfour MH, Kassem AA, Salama A, Abd El-Alim SH. (2020). Hydrophobic ion pair loaded self-emulsifying drug delivery system (SEDDS): a novel oral drug delivery approach of cromolyn sodium for management of bronchial asthma. Int J Pharm
585:119494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32505578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Basalo IM, Chahine NO, Kaplun M, et al.  (2007). Chondroitin sulfate reduces the friction coefficient of articular cartilage. J Biomech
40:1847–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17084404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bashyal S, Seo J-E, Choi YW, Lee S. (2021). Bile acid transporter-mediated oral absorption of insulin via hydrophobic ion-pairing approach. J Control Release
338:644–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34481926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bedingfield SK, Colazo JM, Yu F, et al.  (2021). Amelioration of post-traumatic osteoarthritis via nanoparticle depots delivering small interfering RNA to damaged cartilage. Nat Biomed Eng
5:1069–15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8497446</ArticleId>
            <ArticleId IdType="pubmed">34413494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bian L, Kaplun M, Williams DY, et al.  (2009). Influence of chondroitin sulfate on the biochemical, mechanical and frictional properties of cartilage explants in long-term culture. J Biomech
42:286–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2819724</ArticleId>
            <ArticleId IdType="pubmed">19117573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bishnoi M, Jain A, Hurkat P, Jain SK. (2014). Aceclofenac-loaded chondroitin sulfate conjugated SLNs for effective management of osteoarthritis. J Drug Target
22:805–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24955618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boileau C, Tat SK, Pelletier J-P, et al.  (2008). Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling. Arthritis Res Ther
10:R71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2483463</ArticleId>
            <ArticleId IdType="pubmed">18578867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown S, Kumar S, Sharma B. (2019). Intra-articular targeting of nanomaterials for the treatment of osteoarthritis. Acta Biomater
93:239–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6615949</ArticleId>
            <ArticleId IdType="pubmed">30862551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown SB, Wang L, Jungels RR, Sharma B. (2020). Effects of cartilage-targeting moieties on nanoparticle biodistribution in healthy and osteoarthritic joints. Acta Biomater
101:469–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7025912</ArticleId>
            <ArticleId IdType="pubmed">31586725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bryk M, Chwastek J, Mlost J, et al.  (2021). Sodium monoiodoacetate dose-dependent changes in matrix metalloproteinases and inflammatory components as prognostic factors for the progression of osteoarthritis. Front Pharmacol
12:643605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8113822</ArticleId>
            <ArticleId IdType="pubmed">33995052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castro GA, Coelho ALLR, Oliveira CA, et al.  (2009). Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Int J Pharm
381:77–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19647057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng Y, Wang D, Zhang Z, Wang Z. (2015). Solubility and solution thermodynamics of rhein in eight pure solvents from (288.15 to 313.15) K. RSC Adv
5:80548–52.</Citation>
        </Reference>
        <Reference>
          <Citation>Cogswell CJ, Sheppard CJR. (1992). Confocal differential interference contrast (DIC) microscopy: including a theoretical analysis of conventional and confocal DIC imaging. J Microsc
165:81–101.</Citation>
        </Reference>
        <Reference>
          <Citation>dos Santos Duarte Lana JF, Rodrigues BL. (2019). Osteoarthritis as a chronic inflammatory disease: a review of the inflammatory markers. In: Osteoarthritis biomarkers and treatments. London: IntechOpen.</Citation>
        </Reference>
        <Reference>
          <Citation>Ebada HMK, Nasra MMA, Elnaggar YSR, Abdallah OY. (2021). Novel rhein–phospholipid complex targeting skin diseases: development, in vitro, ex vivo, and in vivo studies. Drug Deliv Transl Res
11:1107–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32815084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebada HMK, Nasra MMA, Elnaggar YSR, et al.  (2021). Novel rhein integrate transphytosomes as non-invasive local therapy for osteoarthritis to ameliorate cartilage deterioration in MIA-arthritic rats. Colloids Surf B Biointerfaces
202:111713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33780905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eladawy NO, Morsi NM, Shamma RN. (2021). Diacerein-loaded hyaluosomes as a dual-function platform for osteoarthritis management via intra-articular injection: in vitro characterization and in vivo assessment in a rat model. Pharmaceutics
13:765.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8223785</ArticleId>
            <ArticleId IdType="pubmed">34063749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng H, Zhu Y, Fu Z, Li D. (2017). Preparation, characterization, and in vivo study of rhein solid lipid nanoparticles for oral delivery. Chem Biol Drug Des
90:867–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28432812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernández-Martín S, González-Cantalapiedra A, Muñoz F, et al.  (2021). Glucosamine and chondroitin sulfate: is there any scientific evidence for their effectiveness as disease-modifying drugs in knee osteoarthritis preclinical studies?—A systematic review from 2000 to 2021. Animals
11:1608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8228516</ArticleId>
            <ArticleId IdType="pubmed">34072407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gad HA, Elezaby RS, Mansour M, Hathout RM. (2022). Novel approaches of solid lipid nanoparticles as drug carrier. Nanoeng Biomater Drug Deliv
1:107–43.</Citation>
        </Reference>
        <Reference>
          <Citation>Gerwin N, Bendele AM, Glasson S, Carlson CS. (2010). The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the rat. Osteoarthr Cartilage
18:S24–S34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20864021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gómez-Gaete C, Ferreira F, Bustos P, et al.  (2018). Optimization of rhein-loaded polymeric nanoparticles using a factorial design and evaluation of the cytotoxic and anti-inflammatory effects. Drug Dev Ind Pharm
44:1285–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29482400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gómez-Gaete C, Retamal M, Chávez C, et al.  (2017). Development, characterization and in vitro evaluation of biodegradable rhein-loaded microparticles for treatment of osteoarthritis. Eur J Pharm Sci
96:390–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27721042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu X, Zheng Y. (2015). Preparation, characterization, and in vivo study of rhein-loaded poly(Lactic-co-glycolic acid) nanoparticles for oral delivery, Drug Design. Drug Des Devel Ther
9:2301–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4410823</ArticleId>
            <ArticleId IdType="pubmed">25960633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He K, Huang X, Shan R, et al.  (2022). Intra-articular injection of lornoxicam and microRNA-140 co-loaded cationic liposomes enhanced the therapeutic treatment of experimental osteoarthritis. AAPS PharmSciTech
23:1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34859319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu B, Gao F, Li C, et al.  (2020). Rhein laden pH-responsive polymeric nanoparticles for treatment of osteoarthritis. AMB Express
10:158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7459081</ArticleId>
            <ArticleId IdType="pubmed">32865763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ismail R, Phan TNQ, Laffleur F, et al.  (2020). Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery. Eur J Pharm Biopharm
152:10–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32371152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain A, Mishra SK, Vuddanda PR, et al.  (2014). Targeting of diacerein loaded lipid nanoparticles to intra-articular cartilage using chondroitin sulfate as homing carrier for treatment of osteoarthritis in rats. Nanomedicine
10:e1031–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24512762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain A, Singh S, Singh Y, singh s. (2013). Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects. J Biomed Nanotechnol
9:891–900.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23802421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jalil A, Asim MH, Nazir I, et al.  (2020). Self-emulsifying drug delivery systems containing hydrophobic ion pairs of polymyxin B and agaric acid: a decisive strategy for enhanced antimicrobial activity. J Mol Liq
311:113298.</Citation>
        </Reference>
        <Reference>
          <Citation>Jansen MP, Mastbergen SC. (2022). Joint distraction for osteoarthritis: clinical evidence and molecular mechanisms. Nat Rev Rheumatol
18:35–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34616035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janssen M, Timur UT, Woike N, et al.  (2016). Celecoxib-loaded PEA microspheres as an auto regulatory drug-delivery system after intra-articular injection. J Control Release
244:30–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27836707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung JH, Kim SE, Kim H-J, et al.  (2020). A comparative pilot study of oral diacerein and locally treated diacerein-loaded nanoparticles in a model of osteoarthritis. Int J Pharm
581:119249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32217157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaur A, Bhoop BS, Chhibber S, et al.  (2017). Supramolecular nano-engineered lipidic carriers based on diflunisal-phospholipid complex for transdermal delivery: QbD based optimization, characterization and preclinical investigations for management of rheumatoid arthritis. Int J Pharm
533:206–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28943207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Latourte A, Kloppenburg M, Richette P. (2020). Emerging pharmaceutical therapies for osteoarthritis. Nat Rev Rheumatol
16:673–88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33122845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawson TB, Mäkelä JTA, Klein T, et al.  (2021). Nanotechnology and osteoarthritis. Part 2: opportunities for advanced devices and therapeutics. J Orthop Res
39:473–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32860444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leonidou A, Lepetsos P, Mintzas M, et al.  (2018). Inducible nitric oxide synthase as a target for osteoarthritis treatment. Expert Opin Ther Targets
22:299–318.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29504411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li G, Lee WJ, Tan CP, et al.  (2021). Tailored rigidity of W/O Pickering emulsions using diacylglycerol-based surface-active solid lipid nanoparticles. Food Funct
12:11732–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34698749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li G-M, Chen J-R, Zhang H-Q, et al.  (2021). Update on pharmacological activities, security, and pharmacokinetics of rhein. Evid Based Complement Alternat Med
2021:4582412. ().</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8387172</ArticleId>
            <ArticleId IdType="pubmed">34457021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Zheng Y, Shan FY, et al.  (2013). Development of ionic-complex-based nanostructured lipid carriers to improve the pharmacokinetic profiles of breviscapine. Acta Pharmacol Sin
34:1108–15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4003023</ArticleId>
            <ArticleId IdType="pubmed">23770990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang Y, Xu X, Xu L, et al.  (2021). Non-surgical osteoarthritis therapy, intra-articular drug delivery towards clinical applications. J Drug Target
29:609–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33356642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo J, Zhang Z, Zeng Y, et al.  (2021). Co-encapsulation of collagenase type I and silibinin in chondroitin sulfate coated multilayered nanoparticles for targeted treatment of liver fibrosis. Carbohydr Polym
263:117964.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33858569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malkawi A, Jalil A, Nazir I, et al.  (2020). Self-emulsifying drug delivery systems: hydrophobic drug polymer complexes provide a sustained release in vitro. Mol Pharmaceutics
17:3709–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7539300</ArticleId>
            <ArticleId IdType="pubmed">32841038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mancipe Castro LM, García AJ, Guldberg RE. (2021). Biomaterial strategies for improved intra-articular drug delivery . J Biomed Mater Res A
109:426–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32780515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin G, Bogdanowicz P, Domagala F, et al.  (2003). Rhein inhibits interleukin-1β-induced activation of MEK/ERK pathway and DNA binding of NF-κB and AP-1 in chondrocytes cultured in hypoxia: a potential mechanism for its disease-modifying effect in osteoarthritis. Inflammation
27:233–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14527176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maudens P, Jordan O, Allémann E. (2018). Recent advances in intra-articular drug delivery systems for osteoarthritis therapy. Drug Discovery Today
23:1761–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29792929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Migliore A, Paoletta M, Moretti A, et al.  (2020). The perspectives of intra-articular therapy in the management of osteoarthritis. Expert Opin Drug Deliv
17:1213–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32543240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moldovan F, Pelletier J, Jolicoeur FC, et al.  (2000). Diacerhein and rhein reduce the ICE-induced IL-1β and IL-18 activation in human osteoarthritic cartilage. Osteoarthritis and Cartilage
8:186–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10806046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morales M, Irlandini E. (2022). Conservative treatments of osteochondral lesions of the knee. In: Gobbi A, Lane JG, Longo UG, Dallo I, eds. Joint function preservation: a focus on the osteochondral unit. Cham: Springer International Publishing, 375–87.</Citation>
        </Reference>
        <Reference>
          <Citation>Naveen SV, Ahmad RE, Hui WJ, et al.  (2014). Histology, glycosaminoglycan level and cartilage stiffness in monoiodoacetate-induced osteoarthritis: comparative analysis with anterior cruciate ligament transection in rat model and human osteoarthritis. Int J Med Sci
11:97–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3880996</ArticleId>
            <ArticleId IdType="pubmed">24396291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paliwal R, Paliwal SR, Kenwat R, et al.  (2020). Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opin Ther Pat
30:179–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32003260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pelletier J-P, Raynauld J-P, Beaulieu AD, et al.  (2016). Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study. Arthritis Res Ther
18:256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5094139</ArticleId>
            <ArticleId IdType="pubmed">27809891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng Z, Sun H, Bunpetch V, et al.  (2021). The regulation of cartilage extracellular matrix homeostasis in joint cartilage degeneration and regeneration. Biomaterials
268:120555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33285440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petralito S, Zanardi I, Memoli A, et al.  (2009). Solubility, spectroscopic properties and photostability of Rhein/cyclodextrin inclusion complex. Spectrochim Acta A Mol Biomol Spectrosc
74:1254–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19857988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pradal J, Maudens P, Gabay C, et al.  (2016). Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice. Int J Pharm
498:119–29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26685724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pritzker KPH, Gay S, Jimenez SA, et al.  (2006). Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage
14:13–29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16242352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rabiei M, Kashanian S, Samavati SS, et al.  (2021). Nanotechnology application in drug delivery to osteoarthritis (OA), rheumatoid arthritis (RA), and osteoporosis (OSP). J Drug Delivery Sci Technol
61:102011.</Citation>
        </Reference>
        <Reference>
          <Citation>Reginster J-Y, Veronese N. (2021). Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment. Aging Clin Exp Res
33:37–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7897612</ArticleId>
            <ArticleId IdType="pubmed">32638342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ristroph K, Salim M, Wilson BK, et al.  (2021). Internal liquid crystal structures in nanocarriers containing drug hydrophobic ion pairs dictate drug release. J Colloid Interface Sci
582:815–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32911422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodrigues LBO, Lima FA, Alves CPB, et al.  (2020). Ion pair strategy in solid lipid nanoparticles: a targeted approach to improve epidermal targeting with controlled adapalene release, resulting reduced skin irritation. Pharm Res
37:148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32681288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacchetti C, Liu-Bryan R, Magrini A, et al.  (2014). Polyethylene-glycol-modified single-walled carbon nanotubes for intra-articular delivery to chondrocytes. ACS Nano
8:12280–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4373402</ArticleId>
            <ArticleId IdType="pubmed">25415768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schöngen RN, Giannetti BM, van de Leur E, et al.  (1988). Effect of diacetylrhein on the phagocytosis of polymorphonuclear leucocytes and its influence on the biosynthesis of hyaluronate in synovial cells. Arzneimittelforschung
38:744–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3415721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sobal G, Dorotka R, Menzel J, Sinzinger H. (2013). Uptake studies with chondrotropic 99mTc-chondroitin sulfate in articular cartilage. Implications for imaging osteoarthritis in the knee. Nucl Med Biol
40:1013–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24011535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sobal G, Menzel EJ, Sinzinger H. (2008). Radiolabeling procedure, quality control and stability of 99mTc-labeled chondroitin sulfate: a new approach of targeting osteoarthritis. Appl Radiat Isot
66:415–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18093837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sobal G, Velusamy K, Kosik S, et al.  (2016). Preclinical evaluation of (99m)Tc labeled chondroitin sulfate for monitoring of cartilage degeneration in osteoarthritis. Nucl Med Biol
43:339–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27135710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun H, Luo G, Chen D, Xiang Z. (2016). A comprehensive and system review for the pharmacological mechanism of action of rhein, an active anthraquinone ingredient. Front Pharmacol
7:247.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4987408</ArticleId>
            <ArticleId IdType="pubmed">27582705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van den Bosch MHJ. (2021). Osteoarthritis year in review 2020: biology. Osteoarthritis and Cartilage
29: 143–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33242602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Yang D, Li L, et al.  (2020). Anti-inflammatory Effects and Mechanisms of Rhein, an Anthraquinone Compound, and Its Applications in Treating Arthritis: A Review. Nat Prod Bioprospect
10:445–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7648819</ArticleId>
            <ArticleId IdType="pubmed">33128198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao S, Lin Y, Tang Y, et al.  (2021). Real-time quantification of cartilage degeneration by GAG-targeted cationic nanoparticles for efficient therapeutic monitoring in living mice. Mol Pharm
18:1444–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33538605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin X-f, Wang L-l, Chu X-c. (2017). A novel chondroitin sulfate decorated nano platinum for the treatment of osteoarthritis. Mater Sci Eng C Mater Biol Appl
78:452–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28576008</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
